FISCAL NOTE
Date Requested: January 16, 2026
Time Requested: 04:00 PM |
| Agency: |
Public Health, Bureau for |
|---|
| CBD Number: |
Version: |
Bill Number: |
Resolution Number: |
| 1184 |
Introduced |
SB463 |
|
|---|
| CBD Subject: |
Health |
|---|
|
FUND(S):
0419 - DEPARTMENT OF HEALTH - OFFICE OF LABORTORY SERVICES, 5163 - LABORATORY SERVICES FUND
Sources of Revenue:
General Fund Special
Legislation creates:
Fiscal Note Summary
Effect this measure will have on costs and revenues of state government.
The purpose of this bill is to enact a mandate for newborn testing for mucopolysaccharidosis type 1 (MPS1), a metabolic disorder, which although not curable, can be treated if diagnosed in young infants.
No fiscal impact as the Department began this testing approximately two years ago.
Fiscal Note Detail
| Effect of Proposal |
Fiscal Year |
2026
Increase/Decrease
(use"-") |
2027
Increase/Decrease
(use"-") |
Fiscal Year
(Upon Full
Implementation) |
| 1. Estmated Total Cost |
0 |
0 |
0 |
| Personal Services |
0 |
0 |
0 |
| Current Expenses |
0 |
0 |
0 |
| Repairs and Alterations |
0 |
0 |
0 |
| Assets |
0 |
0 |
0 |
| Other |
0 |
0 |
0 |
| 2. Estimated Total Revenues |
0 |
0 |
0 |
Explanation of above estimates (including long-range effect):
Memorandum
Person submitting Fiscal Note: Arvin Singh, Secretary, EdD, MBA, MPH, MS, FACHE
Email Address: OSAfiscalnotes@wv.gov